VSV-hIFNbeta-NIS With or Without Ruxolitinib Phosphate in Treating Stage IV or Recurrent Endometrial Cancer
ACTIVE_NOT_RECRUITING
Status
Conditions
- Metastatic Endometrial Carcinoma
- Recurrent Endometrial Adenocarcinoma
- Recurrent Endometrial Carcinoma
- Recurrent Endometrial Clear Cell Adenocarcinoma
- Recurrent Endometrial Endometrioid Adenocarcinoma
- Recurrent Endometrial Mixed Cell Adenocarcinoma
- Recurrent Endometrial Serous Adenocarcinoma
- Recurrent Endometrial Undifferentiated Carcinoma
- Recurrent Uterine Corpus Carcinosarcoma
- Stage IV Uterine Corpus Cancer AJCC v7
Interventions
- PROCEDURE: Biopsy
- PROCEDURE: Computed Tomography
- OTHER: Fluorine F 18 Tetrafluoroborate
- OTHER: Pharmacological Study
- PROCEDURE: Positron Emission Tomography
- BIOLOGICAL: Recombinant Vesicular Stomatitis Virus-expressing Human Interferon Beta and Sodium-Iodide Symporter
- DRUG: Ruxolitinib Phosphate
- DRUG: Technetium Tc-99m Sodium Pertechnetate
- PROCEDURE: Biospecimen Collection
Sponsor
Mayo Clinic
Collaborators